Literature DB >> 8088454

Competence to undergo normal, fertilization-induced cortical activation develops after metaphase I of meiosis in mouse oocytes.

T Ducibella1, J Buetow.   

Abstract

The purpose of this study was to determine at what stage of meiotic maturation mouse oocytes develop the ability to undergo sperm-induced activation, assayed by cortical granule (CG) release. Germinal vesicle breakdown (GVBD), prometaphase I (proMI), metaphase I (MI), and metaphase II (MII, the normal stage at fertilization) stages were evaluated by quantitative image analysis. At 2 hr, fertilized MII eggs underwent a mean CG loss of 69%; loss was global--in the entire cortex occupied by CGs. In contrast, fertilized GVBD and proMI oocytes had no significant CG loss in the cortex after 2 hr. After 4 hr, 63, 67, and 88% of fertilized GVBD, proMI, and MI oocytes, respectively, had localized CG release only in the vicinity of the fertilizing sperm. At 4 hr, GVBD oocytes had small sperm-associated, CG-depleted domains, approximately 100 microns 2 (< 1% of the oocyte cortex), whereas those for proMI oocytes were approximately 2500 microns 2. The CG density was reduced by 90% in these domains, whereas the remaining cortex showed no evidence of CG loss. Both the extent and time course of CG loss were altered in oocytes fertilized before MII and were not significantly affected with 25 microM thimerosal, which sensitizes egg calcium stores. Unlike the ability to undergo CG release, the ability to initiate sperm chromatin decondensation was not stage specific and the extent of decondensation was cell cycle related. Competence to undergo CG loss develops in two phases: the ability to undergo localized CG release increases between the GV and MI stages, whereas the mechanism of propagating a normal wave of global CG loss from the site of sperm entry develops between MI and MII.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8088454     DOI: 10.1006/dbio.1994.1237

Source DB:  PubMed          Journal:  Dev Biol        ISSN: 0012-1606            Impact factor:   3.582


  7 in total

1.  Covalent genomic DNA modification patterns revealed by denaturing gradient gel blots.

Authors:  Shari L Laprise; Mark R Gray
Journal:  Gene       Date:  2006-12-12       Impact factor: 3.688

2.  SNAP23 is required for constitutive and regulated exocytosis in mouse oocytes†.

Authors:  Lisa M Mehlmann; Tracy F Uliasz; Katie M Lowther
Journal:  Biol Reprod       Date:  2019-08-01       Impact factor: 4.285

3.  The association between polypronucleate zygote formation with certain motion characteristics of sperm and IVF outcome.

Authors:  Tsung-Hsien Lee; Chung-Hsien Liu; Chun-Chia Huang; Hsui-Hui Chen; Shee-Uan Chen; Maw-Sheng Lee
Journal:  J Assist Reprod Genet       Date:  2008-01-19       Impact factor: 3.412

4.  Reproductive Performance of Holstein Dairy Cows Grazing in Dry-summer Subtropical Climatic Conditions: Effect of Heat Stress and Heat Shock on Meiotic Competence and In vitro Fertilization.

Authors:  Krishna Pavani; Isabel Carvalhais; Marwa Faheem; Antonio Chaveiro; Francisco Vieira Reis; Fernando Moreira da Silva
Journal:  Asian-Australas J Anim Sci       Date:  2015-03       Impact factor: 2.509

5.  Effects of sperm insemination on the final meiotic maturation of mouse oocytes arrested at metaphase I after in vitro maturation.

Authors:  Jeong Yoon; Kyoung-Mi Juhn; San-Hyun Yoon; Yong Ko; Jin-Ho Lim
Journal:  Clin Exp Reprod Med       Date:  2017-03-31

6.  A Unique Egg Cortical Granule Localization Motif Is Required for Ovastacin Sequestration to Prevent Premature ZP2 Cleavage and Ensure Female Fertility in Mice.

Authors:  Bo Xiong; Yangu Zhao; Stephanie Beall; Anna Burkart Sadusky; Jurrien Dean
Journal:  PLoS Genet       Date:  2017-01-23       Impact factor: 5.917

7.  Live imaging of cortical granule exocytosis reveals that in vitro matured mouse oocytes are not fully competent to secrete their content.

Authors:  Andrea I Cappa; Matilde de Paola; Paula Wetten; Gerardo A De Blas; Marcela A Michaut
Journal:  Biol Open       Date:  2018-12-03       Impact factor: 2.422

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.